Research graph
References from Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1146/annurev-biochem-061516-045115
10.1146/annurev-biochem-061516-045115 · External reference
10.1111/joim.12506
10.1111/joim.12506 · External reference
10.1016/j.bpc.2021.106699
10.1016/j.bpc.2021.106699 · External reference
Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
10.1080/13506129.2020.1835263 · 2020 · External reference
Single-molecule studies of amyloid proteins: from biophysical properties to diagnostic perspectives
10.1017/s0033583520000086 · 2020 · External reference
10.1002/anie.202104497
10.1002/anie.202104497 · External reference
Structural symmetry and protein function
10.1146/annurev.biophys.29.1.105 · 2000 · External reference
10.1042/bst20190283
10.1042/bst20190283 · External reference
10.1038/aps.2017.28
10.1038/aps.2017.28 · External reference
10.1113/jphysiol.2006.111203
10.1113/jphysiol.2006.111203 · External reference
10.1016/j.bpc.2020.106505
10.1016/j.bpc.2020.106505 · External reference
10.1016/j.bpc.2020.106507
10.1016/j.bpc.2020.106507 · External reference
10.1021/acs.chemrev.0c01122
10.1021/acs.chemrev.0c01122 · External reference
10.1074/jbc.r116.714576
10.1074/jbc.r116.714576 · External reference
Lecanemab in early Alzheimer’s disease
10.1056/nejmoa2212948 · 2023 · External reference
10.1038/s41591-019-0675-0
10.1038/s41591-019-0675-0 · External reference
10.1074/jbc.r800009200
10.1074/jbc.r800009200 · External reference
10.1146/annurev.genom.1.1.507
10.1146/annurev.genom.1.1.507 · External reference
APOE alleles and extreme human longevity
10.1093/gerona/gly174 · 2019 · External reference
10.1016/j.nbd.2022.105631
10.1016/j.nbd.2022.105631 · External reference
APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review
2020 · External reference
APOE alleles and diet in brain aging and Alzheimer’s disease
10.3389/fnagi.2020.00150 · 2020 · External reference
10.1073/pnas.1705080114
10.1073/pnas.1705080114 · External reference
10.1073/pnas.1106420108
10.1073/pnas.1106420108 · External reference
APOE genotype regulates pathology and disease progression in synucleinopathy
10.1126/scitranslmed.aay3069 · 2020 · External reference
10.1016/s0140-6736(94)90691-2
10.1016/s0140-6736(94)90691-2 · External reference
Dissecting the association of apolipoprotein E gene polymorphisms with type 2 diabetes mellitus and coronary artery disease
2022 · External reference
The role of apoE4 in disrupting the homeostatic functions of astrocytes and microglia in aging and Alzheimer’s disease
2019 · External reference
10.1007/s00109-018-1632-y
10.1007/s00109-018-1632-y · External reference
10.1038/nature11087
10.1038/nature11087 · External reference
10.1194/jlr.r800069-jlr200
10.1194/jlr.r800069-jlr200 · External reference
10.1016/s0021-9258(18)34954-8
10.1016/s0021-9258(18)34954-8 · External reference
10.3233/jad-190175
10.3233/jad-190175 · External reference
10.1073/pnas.151254698
10.1073/pnas.151254698 · External reference
APOE-amyloid interaction: therapeutic targets
2020 · External reference
The amyloid hypothesis of Alzheimer’s disease at 25 years
10.15252/emmm.201606210 · 2016 · External reference
10.1194/jlr.r075481
10.1194/jlr.r075481 · External reference
10.1007/s007020200068
10.1007/s007020200068 · External reference
10.1038/nrm2101
10.1038/nrm2101 · External reference
Amyloid structure exhibits polymorphism on multiple length scales in human brain tissue
2016 · External reference
The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer’s disease
10.1016/s0306-4522(01)00169-5 · 2001 · External reference
10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x · External reference
10.1097/nen.0b013e318217a118
10.1097/nen.0b013e318217a118 · External reference
The effects of APOE and tau gene variability on risk of frontotemporal dementia
10.1016/j.neurobiolaging.2005.03.008 · 2006 · External reference
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5000-person neuropathological study
2020 · External reference
Resistance to autosomal dominant Alzheimer’s in an APOE3-Christchurch homozygote: a case report
10.1038/s41591-019-0611-3 · 2019 · External reference
Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk
2014 · External reference
10.1016/j.neuron.2014.01.045
10.1016/j.neuron.2014.01.045 · External reference
Amyloid-beta–copper interaction studied by simultaneous nitrogen K and copper L2,3-edge soft X-ray absorption spectroscopy
10.1016/j.isci.2021.103465 · 2021 · External reference
10.1074/jbc.271.18.10602
10.1074/jbc.271.18.10602 · External reference
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
2013 · External reference
10.1016/j.neuron.2009.06.026
10.1016/j.neuron.2009.06.026 · External reference
NGF and BDNF signaling control amyloidogenic route and Aβ production in hippocampal neurons
10.1073/pnas.0806133105 · 2008 · External reference
10.1073/pnas.0508693102
10.1073/pnas.0508693102 · External reference
10.1016/j.cell.2016.12.044
10.1016/j.cell.2016.12.044 · External reference
10.1042/bcj20180068
10.1042/bcj20180068 · External reference
10.1016/j.neuron.2007.08.008
10.1016/j.neuron.2007.08.008 · External reference
10.1021/bi5008172
10.1021/bi5008172 · External reference
Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice
2014 · External reference
Brain ApoA-I, ApoJ and ApoE immunodetection in cerebral amyloid angiopathy
10.3389/fneur.2019.00187 · 2019 · External reference
Structural interaction of apolipoprotein A-I mimetic peptide with amyloid-β generates toxic hetero-oligomers
10.1016/j.jmb.2019.12.005 · 2020 · External reference
Amyloid-peptide β 42 enhances the oligomerization and neurotoxicity of apoE4: the C-terminal residues Leu279, Lys282 and Gln284 modulate the structural and functional properties of apoE4
10.1016/j.neuroscience.2018.10.026 · 2018 · External reference
The early events that initiate β-amyloid aggregation in Alzheimer’s disease
10.3389/fnagi.2018.00359 · 2018 · External reference
ApoE-fragment/Aβ heteromers in the brain of patients with Alzheimer’s disease
10.1038/s41598-019-40438-4 · 2019 · External reference
10.1016/j.neuron.2008.04.010
10.1016/j.neuron.2008.04.010 · External reference
The role of APOE and TREM2 in Alzheimer′s disease—current understanding and perspectives
2019 · External reference
10.1172/jci36663
10.1172/jci36663 · External reference
10.1002/glia.21004
10.1002/glia.21004 · External reference
10.1002/glia.22619
10.1002/glia.22619 · External reference
10.1523/jneurosci.3442-16.2017
10.1523/jneurosci.3442-16.2017 · External reference
10.1016/j.neuron.2016.08.027
10.1016/j.neuron.2016.08.027 · External reference
10.1016/j.bbi.2012.07.003
10.1016/j.bbi.2012.07.003 · External reference
10.1523/jneurosci.0350-15.2016
10.1523/jneurosci.0350-15.2016 · External reference
Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: relevance to accumulation of Aβ in Alzheimer’s disease
10.1016/j.bbadis.2015.08.025 · 2016 · External reference
10.1371/journal.pcbi.1000663
10.1371/journal.pcbi.1000663 · External reference
10.1084/jem.20121274
10.1084/jem.20121274 · External reference
10.1073/pnas.0604011103
10.1073/pnas.0604011103 · External reference
10.1007/s12264-013-1422-z
10.1007/s12264-013-1422-z · External reference
10.1152/physrev.00024.2003
10.1152/physrev.00024.2003 · External reference
10.1016/j.brainresbull.2016.08.018
10.1016/j.brainresbull.2016.08.018 · External reference
10.1016/j.neurobiolaging.2006.02.001
10.1016/j.neurobiolaging.2006.02.001 · External reference
10.1007/s00401-014-1266-2
10.1007/s00401-014-1266-2 · External reference
10.1038/nature24016
10.1038/nature24016 · External reference
10.1073/pnas.0508254102
10.1073/pnas.0508254102 · External reference
Hypothesis: microtubule instability and paired helical filament formation in the alzheimer disease brain are related to apolipoprotein E genotype
10.1006/exnr.1994.1019 · 1994 · External reference
10.1016/0304-3940(95)11649-h
10.1016/0304-3940(95)11649-h · External reference
10.1523/jneurosci.4315-03.2004
10.1523/jneurosci.4315-03.2004 · External reference
10.1073/pnas.1434398100
10.1073/pnas.1434398100 · External reference
Apolipoprotein E (ApoE) peptide regulates tau phosphorylation via two different signaling pathways
10.1002/(sici)1097-4547(19980301)51:5<658::aid-jnr13>3.0.co;2-z · 1998 · External reference
Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase. Modulation by zinc
10.1074/jbc.m408127200 · 2004 · External reference
10.1016/j.mcn.2017.07.002
10.1016/j.mcn.2017.07.002 · External reference
10.1096/fj.02-0434fje
10.1096/fj.02-0434fje · External reference
Tau hyperphosphorylation in apolipoprotein E-deficient and control mice after closed head injury
10.1002/(sici)1097-4547(20000515)60:4<559::aid-jnr15>3.0.co;2-k · 2000 · External reference
Apolipoprotein e decreases tau kinases and phospho-Tau levels in primary neurons
2006 · External reference
10.1111/jnc.14810
10.1111/jnc.14810 · External reference
10.1523/jneurosci.3821-06.2006
10.1523/jneurosci.3821-06.2006 · External reference
The fusogenic tilted peptide (67–78) of α-synuclein is a cholesterol binding domain
10.1016/j.bbamem.2011.06.017 · 2011 · External reference
10.1038/35081564
10.1038/35081564 · External reference
α-Synuclein promoter confers susceptibility to Parkinson’s disease
10.1002/ana.20268 · 2004 · External reference
α-synuclein–lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson’s disease patients
10.1073/pnas.1821409116 · 2019 · External reference
10.1006/geno.2002.6707
10.1006/geno.2002.6707 · External reference
Apolipoprotein E ε4 allele in familial and sporadic Parkinson’s disease
10.1016/j.neulet.2006.07.037 · 2006 · External reference
Association between apolipoprotein e genotypes and Parkinson’s disease
10.1016/j.jocn.2011.01.028 · 2011 · External reference
10.1007/s00415-009-0119-8
10.1007/s00415-009-0119-8 · External reference
10.1007/s12031-017-0967-0
10.1007/s12031-017-0967-0 · External reference
10.1016/j.plipres.2010.05.004
10.1016/j.plipres.2010.05.004 · External reference
10.1016/j.neulet.2016.02.042
10.1016/j.neulet.2016.02.042 · External reference
Serum cholesterol levels and the risk of Parkinson’s disease
10.1093/aje/kwj283 · 2006 · External reference
Low LDL cholesterol and increased risk of Parkinson’s disease: prospective results from Honolulu-Asia aging study
10.1002/mds.22013 · 2008 · External reference
10.1016/j.ajpath.2011.07.021
10.1016/j.ajpath.2011.07.021 · External reference
10.1038/nn2058
10.1038/nn2058 · External reference
Proteomic profiling of PrP27-30-enriched preparations extracted from the brain of hamsters with experimental scrapie
10.1002/pmic.200900085 · 2009 · External reference
10.1021/acs.jproteome.6b00633
10.1021/acs.jproteome.6b00633 · External reference
Immunohistochemical detection of apolipoprotein E within prion-associated lesions in squirrel monkey brains
10.1007/s004010000200 · 2000 · External reference
Recombinant neural protein PrP can bind with both recombinant and native apolipoprotein E in vitro
10.1111/j.1745-7270.2006.00209.x · 2006 · External reference
Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt-Jakob disease phenotype
10.1016/s0304-3940(01)02264-9 · 2001 · External reference
APOE gene polymorphisms and susceptibility to Creutzfeldt-Jakob disease
10.1016/j.jocn.2013.07.019 · 2014 · External reference
Genetic cross-interaction between apoe and prnp in sporadic alzheimer’s and Creutzfeldt-Jakob diseases
10.1371/journal.pone.0022090 · 2011 · External reference
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins
10.1186/s40478-019-0706-6 · 2019 · External reference
Islet amyloid polypeptide: structure, function, and pathophysiology
2016 · External reference
Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology
10.1016/j.sbi.2012.11.003 · 2013 · External reference
10.1073/pnas.1219059110
10.1073/pnas.1219059110 · External reference
The role of cholesterol in driving IAPP-membrane interactions
10.1016/j.bpj.2016.05.050 · 2016 · External reference
10.1021/acs.chemrev.0c00981
10.1021/acs.chemrev.0c00981 · External reference
10.1021/acschemneuro.5b00325
10.1021/acschemneuro.5b00325 · External reference
Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes
10.1186/s12916-017-0901-x · 2017 · External reference
10.1002/(sici)1096-9896(199608)179:4<443::aid-path612>3.0.co;2-7
10.1002/(sici)1096-9896(199608)179:4<443::aid-path612>3.0.co;2-7 · External reference
The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice
10.1007/s00125-002-0984-5 · 2003 · External reference
Histopathological correlations of islet amyloidosis with apolipoprotein e polymorphisms in type 2 diabetic Chinese patients
10.1097/mpa.0b013e3182965e6e · 2013 · External reference
Association between amylin and amyloid-β peptides in plasma in the context of apolipoprotein E4 allele
2014 · External reference
Apolipoprotein E interferes with IAPP aggregation and protects pericytes from IAPP-induced toxicity
10.3390/biom10010134 · 2020 · External reference
10.1016/j.bbrc.2008.01.103
10.1016/j.bbrc.2008.01.103 · External reference
Ganglioside-induced amyloid formation by human islet amyloid polypeptide in lipid rafts
10.1016/j.febslet.2009.07.044 · 2009 · External reference
10.1016/j.febslet.2013.01.046
10.1016/j.febslet.2013.01.046 · External reference
10.1021/acs.chemrev.5b00407
10.1021/acs.chemrev.5b00407 · External reference
Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene
10.1007/s11910-996-0008-9 · 2006 · External reference
10.1016/j.jns.2008.06.025
10.1016/j.jns.2008.06.025 · External reference
10.1016/s0304-3940(02)01159-x
10.1016/s0304-3940(02)01159-x · External reference
10.1002/ana.1252
10.1002/ana.1252 · External reference
10.1016/s0022-510x(01)00569-x
10.1016/s0022-510x(01)00569-x · External reference
10.1007/s10048-004-0193-0
10.1007/s10048-004-0193-0 · External reference
10.1016/j.mcn.2017.07.001
10.1016/j.mcn.2017.07.001 · External reference
10.1016/j.expneurol.2012.05.018
10.1016/j.expneurol.2012.05.018 · External reference
TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
10.1001/archneur.64.10.1388 · 2007 · External reference
10.1093/hmg/ddq137
10.1093/hmg/ddq137 · External reference
10.1097/nen.0b013e31817713b5
10.1097/nen.0b013e31817713b5 · External reference
10.1111/j.1440-1789.2009.01017.x
10.1111/j.1440-1789.2009.01017.x · External reference
10.1016/s1474-4422(17)30284-3
10.1016/s1474-4422(17)30284-3 · External reference
10.1016/s1474-4422(18)30251-5
10.1016/s1474-4422(18)30251-5 · External reference
10.1007/s00401-014-1269-z
10.1007/s00401-014-1269-z · External reference
10.1038/s41374-019-0196-y
10.1038/s41374-019-0196-y · External reference
10.1016/j.brainres.2011.02.052
10.1016/j.brainres.2011.02.052 · External reference
10.1038/nrn3121
10.1038/nrn3121 · External reference
Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients
2014 · External reference
Abnormal TDP‐43 function impairs activity‐dependent BDNF secretion, synaptic plasticity, and cognitive behavior through altered Sortilin splicing
2019 · External reference
Associations between ApoEε4 carrier status and serum BDNF levels—new insights into the molecular mechanism of ApoEε4 actions in Alzheimer’s disease
10.1007/s12035-014-8804-8 · 2015 · External reference
Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer’s disease
10.3233/jad-140849 · 2014 · External reference
Decreased neurotrophic support is associated with cognitive decline in non-demented subjects
10.3233/jad-150172 · 2015 · External reference
Transthyretin amyloidosis and two other aging-related amyloidoses in an aged vervet monkey
10.1354/vp.45-1-67 · 2008 · External reference
10.1016/s0014-5793(98)00234-8
10.1016/s0014-5793(98)00234-8 · External reference
Transthyretin sequesters amyloid β protein and prevents amyloid formation
10.1073/pnas.91.18.8368 · 1994 · External reference
Pathological aspects of beta-2-microglobulin amyloidosis
10.1046/j.1525-139x.2001.00037.x · 2001 · External reference
Current clinical and pathogenetic understanding of β2-m amyloidosis in long-term haemodialysis patients
10.1046/j.1440-1797.8.s.10.x · 2003 · External reference
A systematic study of the effect of physiological factors on β2-microglobulin amyloid formation at neutral pH
10.1021/bi052434i · 2006 · External reference
Apolipoprotein E inhibits the depolymerization of β2-microglobulin-related amyloid fibrils at a neutral pH
10.1021/bi0027128 · 2001 · External reference
Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice
1997 · External reference
Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice
1998 · External reference
ApoE4-specific misfolded intermediate identified by molecular dynamics simulations
10.1371/journal.pcbi.1004359 · 2015 · External reference
10.1016/j.bbapap.2020.140535
10.1016/j.bbapap.2020.140535 · External reference
Apolipoprotein E4 forms a molten globule: a potential basis for its association with disease
10.1074/jbc.m204898200 · 2002 · External reference
Phase separation of RNA-binding proteins in physiology and disease: an introduction to the JBC reviews thematic series
10.1074/jbc.rev119.007944 · 2019 · External reference
Tau protein liquid–liquid phase separation can initiate tau aggregation
10.15252/embj.201798049 · 2018 · External reference
10.1016/j.str.2016.07.007
10.1016/j.str.2016.07.007 · External reference
10.1074/jbc.rev118.001188
10.1074/jbc.rev118.001188 · External reference
Apolipoprotein E4 alters astrocyte fatty acid metabolism and lipid droplet formation
10.3390/cells8020182 · 2019 · External reference
10.1038/s41582-019-0228-7
10.1038/s41582-019-0228-7 · External reference
10.1038/nature12481
10.1038/nature12481 · External reference
10.1016/j.bpc.2022.106907
10.1016/j.bpc.2022.106907 · External reference
Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons
10.1016/j.nbd.2006.04.015 · 2006 · External reference
Lipid-binding proteins in brain health and disease
2019 · External reference
10.1016/j.bpc.2021.106718
10.1016/j.bpc.2021.106718 · External reference
10.1146/annurev.biophys.32.110601.141803
10.1146/annurev.biophys.32.110601.141803 · External reference
Motions and interactions of phospholipid head groups at the membrane surface. 3. Dynamic properties of amine-containing head groups
10.1021/bi00528a014 · 1981 · External reference
Metals and cholesterol: two sides of the same coin in Alzheimer’s disease pathology
2014 · External reference
Lipid and lipid raft alteration in aging and neurodegenerative diseases: a window for the development of new biomarkers
2019 · External reference
10.1097/nen.0000000000000103
10.1097/nen.0000000000000103 · External reference
High cholesterol diet induces tau hyperphosphorylation in apolipoprotein e deficient mice
10.1016/j.febslet.2005.10.024 · 2005 · External reference
Prion infection impairs cholesterol metabolism in neuronal cells
10.1074/jbc.m113.535807 · 2014 · External reference
Direct binding of cholesterol to the amyloid precursor protein: an important interaction in lipid-Alzheimer’s disease relationships?
10.1016/j.bbalip.2010.03.008 · 2010 · External reference
Links between copper and cholesterol in Alzheimer’s disease
2013 · External reference
10.1016/j.plipres.2010.09.001
10.1016/j.plipres.2010.09.001 · External reference
10.1016/j.cell.2014.12.019
10.1016/j.cell.2014.12.019 · External reference
10.1016/j.cmet.2017.08.024
10.1016/j.cmet.2017.08.024 · External reference
α-Synuclein regulates neuronal cholesterol efflux
2017 · External reference
10.1016/j.ajpath.2011.05.047
10.1016/j.ajpath.2011.05.047 · External reference
10.1042/bj20040777
10.1042/bj20040777 · External reference
10.1523/jneurosci.5543-03.2004
10.1523/jneurosci.5543-03.2004 · External reference
10.1111/jnc.12637
10.1111/jnc.12637 · External reference
10.15252/embr.201540614
10.15252/embr.201540614 · External reference
Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer’s disease
10.1016/s0005-2736(03)00025-7 · 2003 · External reference
10.1007/s00249-020-01424-1
10.1007/s00249-020-01424-1 · External reference
Amyloidogenic intrinsically disordered proteins: new insights into their self-assembly and their interaction with membranes
10.3390/life10080144 · 2020 · External reference
Cross-talk of membrane lipids and Alzheimer-related proteins
10.1186/1750-1326-8-34 · 2013 · External reference
10.1021/jm3008618
10.1021/jm3008618 · External reference
10.1038/s41591-018-0004-z
10.1038/s41591-018-0004-z · External reference
10.1089/humc.2017.231
10.1089/humc.2017.231 · External reference
10.1016/j.neuron.2017.11.014
10.1016/j.neuron.2017.11.014 · External reference
Targeting apolipoprotein E for Alzheimer’s disease: an industry perspective
2019 · External reference
Alzheimer’s disease genetic risk factor APOE-ε4 also affects normal brain function
10.2174/1567205013666160401115127 · 2016 · External reference
10.1093/brain/awy165
10.1093/brain/awy165 · External reference
10.1016/s0140-6736(06)69113-7
10.1016/s0140-6736(06)69113-7 · External reference
10.17226/23657
10.17226/23657 · External reference
10.1096/fj.201900071r
10.1096/fj.201900071r · External reference
